Bloomberg
Activist Investor Ananym Urges Bio-Techne to Consider Selling
Activist investor Ananym Capital Management has built a stake in Bio-Techne Corp. and is pushing the board to conduct a strategic review that would include a potential sale.
View original source — Bloomberg ↗
Related stories
South China Morning Post
BusinessJun 15, 2026 · 1 min
After US-Iran accord and oil-price plunge, analysts warn of ‘grey area’ for Chinese firms
South China Morning Post
The Punch
BusinessJun 15, 2026 · 1 min
Nigeria’s inflation rose to 15.93% in May – NBS
The Punch
MarketWatch
BusinessJun 15, 2026 · 1 min
Here’s when gas prices will go down now that there’s a deal to end the Iran war
MarketWatch
MarketWatch
BusinessJun 15, 2026 · 1 min
20 growth stocks priced as value stocks
MarketWatch